Fumagillin: Difference between revisions
CSV import |
CSV import |
||
| Line 68: | Line 68: | ||
[[Category:Aspergillus]] | [[Category:Aspergillus]] | ||
[[Category:Microsporidiosis treatments]] | [[Category:Microsporidiosis treatments]] | ||
<gallery> | |||
File:Fumagillin structure.svg|Fumagillin | |||
</gallery> | |||
Latest revision as of 01:06, 20 February 2025
| Fumagillin | |
|---|---|
| [[File:|frameless|220px|alt=|]] | |
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | 23110-15-8 |
| PubChem | 5284447 |
| DrugBank | DB04838 |
| ChemSpider | 4445360 |
| KEGG | D04197 |
Fumagillin is a natural product originally isolated from the fungus Aspergillus fumigatus. It is a complex organic compound that has been studied for its potential antimicrobial and antiparasitic properties. Fumagillin is particularly noted for its activity against microsporidia, a group of spore-forming unicellular parasites that can cause disease in immunocompromised individuals.
Mechanism of Action[edit]
Fumagillin exerts its effects by inhibiting the enzyme methionine aminopeptidase 2 (MetAP2). This inhibition disrupts the protein synthesis in microsporidia, leading to their death. The specific targeting of MetAP2 makes fumagillin a valuable tool in the treatment of microsporidial infections.
Medical Uses[edit]
Fumagillin has been used in the treatment of microsporidiosis, particularly in patients with HIV/AIDS who are more susceptible to these infections. It has also been explored for its potential use in treating intestinal microsporidiosis and other related conditions.
Side Effects[edit]
The use of fumagillin can be associated with several side effects, including gastrointestinal disturbances, hepatotoxicity, and bone marrow suppression. Patients receiving fumagillin should be monitored for these adverse effects, especially if they are on long-term therapy.
Research and Development[edit]
Research is ongoing to develop fumagillin analogs with improved efficacy and reduced toxicity. These efforts aim to enhance the therapeutic potential of fumagillin while minimizing its side effects.
See Also[edit]
References[edit]
<references group="" responsive="1"></references>
External Links[edit]
Drug groups | Encyclopedia | Dictionary | Cancer drugs | OTC | Alternative meds | Drugs | Medications A-Z | FDA approved products | Portal:Pharmacology
| Major chemical drug groups | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| Antimicrobials | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This antimicrobial-related article is a stub. You can help WikiMD by expanding it.
|
-
Fumagillin
